These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11362715)

  • 1. Study says FDA was lax in reacting to threat to blood supply. Food and Drug Administration.
    AIDS Policy Law; 1995 Aug; 10(14):9. PubMed ID: 11362715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
    Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The precautionary principle and emerging biologic risks: lessons from human immunodeficiency virus in blood products.
    Stoto MA
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S10-2. PubMed ID: 16631821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
    Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious disease in the blood supply and the public health response.
    Evatt B
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S4-9. PubMed ID: 16631825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Court upholds $405,000 award against blood banking industry.
    AIDS Policy Law; 1995 Jun; 10(12):1, 10-1. PubMed ID: 11362633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special report: the truth about condoms. Barriers to better condom "killing people"; regulatory, political hurdles stifle development.
    Contracept Technol Update; 1995 Jan; 16(1):1-6. PubMed ID: 12319318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA policy on unapproved drug products: past, present, and future.
    Chhabra R; Kremzner ME; Kiliany BJ
    Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing new tests before transfusion. Who shall decide?
    Schmidt PJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):454-6. PubMed ID: 8166597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion. Blood cleansing deemed safe, but more donors required.
    AIDS Policy Law; 2002 Aug; 17(16):8. PubMed ID: 12236221
    [No Abstract]   [Full Text] [Related]  

  • 15. The good, the bad & the ugly: the political economy of the blood products industry.
    Dubin CS
    Common Factor; 1998 Oct; (No 12):4-5, 8. PubMed ID: 11365880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian inquiry assesses blame for tainted blood supply.
    AIDS Policy Law; 1997 Dec; 12(22):16. PubMed ID: 11364895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congressional panels underfund hemophilia relief bill.
    AIDS Policy Law; 1999 Oct; 14(19):5. PubMed ID: 11367279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.